Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15493038 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Lymphoma
Intervention: Biological: rituximab

Study has passed its completion date and status has not been verified in more than two years.